276
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Dietary Associations with a Breast Cancer Risk Biomarker Depend on Menopause Status

, , &
Pages 1115-1122 | Received 26 May 2015, Accepted 25 Apr 2016, Published online: 11 Aug 2016

References

  • Augustin LSA, Maso LD, Vecchia CL, Parpinel M, Negri E, et al.: Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study. Ann Oncol 12, 1533–1538, 2001.
  • Aune D, Chan DSM, Vieira AR, Rosenblatt DAN, Vieira R, et al.: Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 134, 479–493, 2012.
  • Fay MP, Freedman LS, Clifford CK, and Midthune DN: Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res 57, 3979–3988, 1997.
  • Spencer L, Mann C, Metcalfe M, Webb MB, Pollard C, et al.: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 45, 2077–2086, 2009.
  • Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, et al.: Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. The Lancet 381, 1029–1036, 2013.
  • Lee I-M, Cook NR, Gaziano JM, Gordon D, Ridker PM, et al.: Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294, 56–65, 2005.
  • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al.: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England J Med 334, 1150–1155, 1996.
  • Group HPSC: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23, 2002.
  • Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al.: The SU. VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335–2342, 2004.
  • Martin LJ, Li Q, Melnichouk O, Greenberg C, Minkin S, et al.: A randomized trial of dietary intervention for breast cancer prevention. Cancer Res 71, 123–133, 2011.
  • Stavraky K, Emmons S: Breast cancer in premenopausal and postmenopausal women. J Natl Cancer Inst 53, 647–654, 1974.
  • Cho K, Mabasa L, Bae S, Walters MW, and Park CS: Maternal high-methyl diet suppresses mammary carcinogenesis in female rat offspring. Carcinogenesis 33, 1106–1112, 2012.
  • Ciappio ED, Mason JB, and Crott JW: Maternal one-carbon nutrient intake and cancer risk in offspring. Nutr Rev 69, 561–571, 2011.
  • John EM, Phipps AI, Davis A, and Koo J: Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomark Prevent 14, 2905–2913, 2005.
  • Shimizu H, Ross R, Bernstein L, Yatani R, Henderson B, et al.: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63, 963–966, 1991.
  • Messina M and Hilakivi-Clarke L: Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 61, 792–798, 2009.
  • Allred DC, Mohsin SK, and Fuqua SA: Histological and biological evolution of human premalignant breast disease. Endocrine-Relat Cancer 8, 47–61, 2001.
  • Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, et al.: Benign breast disease and the risk of breast cancer. New England J Med 353, 229–237, 2005.
  • Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, et al.: Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the gail risk model. J Natl Cancer Inst 92, 1217–1227, 2000.
  • Hidaka BH, Li S, Harvey KE, Carlson SE, Sullivan DK, et al.: Omega-3 and Omega-6 fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology. Cancer Prevent Res 8, 359–364, 2015.
  • Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81, 1879–1886, 1989.
  • Fabian C, Kimler B, Mayo M, and Khan S: Breast-tissue sampling for risk assessment and prevention. Endocrine-Relat Cancer 12, 185–213, 2005.
  • Arterburn LM, Hall EB, and Oken H: Distribution, interconversion, and dose response of n−3 fatty acids in humans. Am J Clin Nutr 83, S1467–1476S, 2006.
  • Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, et al.: Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires the Eating at America's Table Study. Am J Epidemiol 154, 1089–1099, 2001.
  • Willett W and Stampfer MJ: Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124, 17–27, 1986.
  • Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, et al.: Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 104, 1905–1916, 2012.
  • Kabat GC, Miller AB, Jain M, and Rohan TE: Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 99, 816–821, 2008.
  • Shrubsole MJ, Shu XO, Li H-L, Cai H, Yang G, et al.: Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 173, 1171–1182, 2011.
  • Bogan KL: Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD precursor vitamins in human nutrition. Ann Rev Nutr 28, 115–130, 2008.
  • Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, et al.: The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res 74, 1166–1178, 2014.
  • Wu W, Kang S, and Zhang D: Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis. Br J Cancer 109, 1926–1944, 2013.
  • Zhang Y-F, Shi W-W, Gao H-F, Zhou L, Hou A-J, et al.: Folate intake and the risk of breast cancer: a dose-response meta-analysis of prospective studies. PloS one 9, e100044, 2014.
  • Gong Z, Ambrosone CB, McCann SE, Zirpoli G, Chandran U, et al.: Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer 134, 1422–1435, 2014.
  • Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genetics 33, 245–254, 2003.
  • Bauer SR, Hankinson SE, Bertone-Johnson ER, and Ding EL: Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine 92, 123–131, 2013.
  • Bertrand K, Rosner B, Eliassen AH, Hankinson S, Rexrode K, et al.: Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat 149, 479–487, 2015.
  • Chen P, Li M, Gu X, Liu Y, Li X, et al.: Higher blood 25 (OH) D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS One 8, e49312, 2013.
  • Kim Y, Franke A, Shvetsov Y, Wilkens L, Cooney R, et al.: Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer 14, 29, 2014.
  • Reimers L, Crew K, Bradshaw P, Santella R, Steck S, et al.: Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control 26, 187–203, 2015.
  • Heinonen OP and Albanes D: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England J Med 330, 1994.
  • Jiang Q: Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radical Biol Med 72, 76–90, 2014.
  • Smolarek AK and Suh N: Chemopreventive activity of vitamin E in breast cancer: a focus on γ-and δ-tocopherol. Nutrients 3, 962–986, 2011.
  • Talegawkar SA, Johnson EJ, Carithers T, Taylor HA, Bogle ML, et al.: Total α-tocopherol intakes are associated with serum α-tocopherol concentrations in African American adults. J Nutr 137, 2297–2303, 2007.
  • Leenders M, Leufkens AM, Siersema PD, Duijnhoven FJ, Vrieling A, et al.: Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the european prospective investigation into cancer and nutrition. Int J Cancer 135, 2930–2939, 2014.
  • Babaknejad N, Sayehmiri F, Sayehmiri K, Rahimifar P, Bahrami S, et al.: The relationship between selenium levels and breast cancer: a systematic review and meta-analysis. Biol Trace Element Res 159, 1–7, 2014.
  • Gerber M: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107 Suppl 2, S228–S239, 2012.
  • Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, et al.: Chemoprevention of breast cancer by fish oil in preclinical models: Trials and Tribulations. Cancer Res 71, 6091–6096, 2011.
  • Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56, 365–379, 2002.
  • Zheng J-S, Hu X-J, Zhao Y-M, Yang J, and Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346, 2013.
  • Fabian CJ, Kimler BF, and Hursting SD: Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res 17, 62, 2015.
  • Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, et al.: Modulation of breast cancer risk biomarkers by high-dose omega-3 fatty acids: Phase II pilot study in premenopausal women. Cancer Prevent Res 8, 912–921, 2015.
  • Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, et al.: Modulation of breast cancer risk biomarkers by high-dose omega-3 fatty acids: Phase II pilot study in postmenopausal women. Cancer Prevent Res 8, 922–931, 2015.
  • Trock BJ, Hilakivi-Clarke L, and Clarke R: Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459–471, 2006.
  • Chajès V, Thiébaut AC, Rotival M, Gauthier E, Maillard V, et al.: Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 167, 1312–1320, 2008.
  • Kohlmeier L, Simonsen N, van't Veer P, Strain JJ, Martin-Moreno JM, et al.: Adipose tissue trans fatty acids and breast cancer in the European community multicenter study on antioxidants, myocardial infarction, and breast cancer. Cancer Epidemiol Biomark Prevent 6, 705–710, 1997.
  • Kristal AR, Peters U, and Potter JD: Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomark Prevent 14, 2826–2828, 2005.
  • Babyak MA: What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Med 66, 411–421, 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.